A Clinical Trial Comparing the Performance of the JACTAX LD DES With the TAXUS Liberte DES.

Trial Profile

A Clinical Trial Comparing the Performance of the JACTAX LD DES With the TAXUS Liberte DES.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Sponsors Boston Scientific Corporation; Labcoat
  • Most Recent Events

    • 05 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 05 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top